{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"OKYO Pharma Limited"},"Symbol":{"label":"Symbol","value":"OKYO"},"Address":{"label":"Address","value":"United Kingdom"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain."},"CompanyUrl":{"label":"Company Url","value":"https://www.okyopharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Gary S. Jacob","title":"Chief Executive Officer & Executive Director"},{"name":"Raj Patil","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}